| EDIT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the EDIT market cap history going back to 3/18/2016:
Also see: EDIT Shares Outstanding History and EDIT YTD Return |
EDIT Market Cap History — Editas Medicine Capitalization Over Time
As of 4/29/2026 Editas Medicine has a market cap of 276.10 million. Investors often follow the EDIT market cap history to compare the size of the company over time.
This page shows EDIT market capitalization trends over time, with 42 market cap datapoints presented, dating back to 3/18/2016.
| EDIT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EDIT Historical Market Cap: -12.57% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EDIT Stock Price Chart |
| About Editas Medicine Inc |
| Editas Medicine, Inc. is a clinical-stage genome editing company. Co. is focused on developing potentially transformative genomic medicines to treat a broad range of serious diseases. It has developed a proprietary gene editing platform based on CRISPR technology. CRISPR uses a protein- ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1), bound to a guide ribonucleic acid (RNA) molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. We show 42 historical shares outstanding datapoints in our EDIT shares outstanding history coverage, used to compute EDIT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EDIT market cap history over the course of time is important for investors interested in comparing EDIT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EDIT versus a peer is one thing; comparing EDIT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EDIT can fluctuate over the course of history. With this page we aim to empower investors researching EDIT by allowing them to research the EDIT market cap history. |
| EDIT Current Stock Quote |
Quotes delayed 20 minutes  Free EDIT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| EDIT Share Performance |
| Market Cap Peers |
| Editas Medicine (EDIT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
EGLT Market Cap History EGRX Market Cap History EHAB Market Cap History EHC Market Cap History EIDX Market Cap History EIGR Market Cap History EKSO Market Cap History ELAB Market Cap History ELAN Market Cap History ELDN Market Cap History More Healthcare companies » |
EDIT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
